Oxatomide
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Trade names | Tinset, Cedlips, Atoxan |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Physiological data | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C27H30N4O |
| Molar mass | 426.553 g/mol |
| 3D model (JSmol) | |
| |
| |
| Template:Xmark | |
|
WikiDoc Resources for Oxatomide |
|
Articles |
|---|
|
Most recent articles on Oxatomide |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Oxatomide at Clinical Trials.gov Clinical Trials on Oxatomide at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Oxatomide
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Oxatomide Discussion groups on Oxatomide Directions to Hospitals Treating Oxatomide Risk calculators and risk factors for Oxatomide
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Oxatomide |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Oxatomide (R35443) is a first-generation antihistamine of the phenylpiperazine class.[1] It was discovered at Janssen Pharmaceutica in 1975. Oxatomide lacks any anticholinergic effects.[1] In addition to its H1 receptor antagonism, it also possesses antiserotonergic actions.[1]
See also
References
- CS1 maint: Multiple names: authors list
- CS1 maint: Unrecognized language
- Articles with short description
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- Articles with changed CASNo identifier
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical pages without DrugBank identifier
- Drugboxes which contain changes to verified fields
- H1 receptor antagonists
- Piperazines
- Benzimidazoles
- Ureas
- Lactams
- Drug
